MSH2 and neoplasm: At univariate analysis for tumour-specific survival, we tested: mutation in TP53; mutation in PTEN; amplification in EGFR; homozygous deletion in CDKN2A; presence of mutation in MMR genes MSH2 and MSH6; presence of TML over 9 mutations/Mb.